Interestingly, we found that patients with tumors whose expression pattern more closely resembles low‐risk tumors (as defined by our low‐risk TC‐Gx profile), had a worse breast cancer‐specific survival, which was partially explained by proliferation status and PAM50 subtypes, but not by estrogen‐receptor status. This evidence concerns the gene ESR1 and breast carcinoma.